Pages that link to "Q44660758"
Jump to navigation
Jump to search
The following pages link to Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer (Q44660758):
Displaying 13 items.
- Monoclonal antibody therapy (Q34236658) (← links)
- Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma (Q34267563) (← links)
- Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo (Q35822882) (← links)
- c-fos oncogene underexpression in salivary gland tumors as measured by in situ hybridization. (Q35832516) (← links)
- C-erbB-2 immunostaining: problems with interpretation (Q37104860) (← links)
- Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell Carcinoma (Q37355025) (← links)
- Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study (Q42859206) (← links)
- Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma (Q58497358) (← links)
- Clear cell carcinoma arising in a pleomorphic adenoma of the submandibular gland (Q71633112) (← links)
- Protein tyrosine (de-)phosphorylation in head and neck squamous cell carcinoma (Q72412739) (← links)
- Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck (Q73305812) (← links)
- Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo (Q73595207) (← links)
- Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands (Q73876250) (← links)